Dr. Asmita Das

Dr. Asmita Das completed BSc (H) Microbiology from Delhi University, Gargi College and master’s degree in Biotechnology from M.S. University, Baroda. She received her PhD in Immunology from Jawaharlal Nehru University, New Delhi. During her PhD she worked on Natural Killer cell development in mouse models and also worked on NK cell interaction with tumor cells. Thereafter she moved to National Institutes of Health, USA for postdoctoral research in the laboratory of Immunogenetics in National Institute of Allergy and Infectious diseases, at NIH, USA. During her postdoctoral research she worked on NK cell signaling in humans. Her work in the field was acclaimed as the top 10% articles in Journal of Immunology (IF:5.6) and also published in reputed peer reviewed journals (Immunity: Impact factor of 43.5). While at NIH she also worked as part of the Fellows Editorial Board of National Cancer Institute at National Institute of Health (NIH), USA.

Her present research interest includes cellular immunology particularly NK cell activity in hepatocarcinoma and NK receptor signaling. She has also pioneered interdisciplinary research in the field of CFD analysis with body fluids in collaboration with the Mechanical Engineering dept at DTU and IIT Delhi.

She is also engaged in collaborative research in the field of Cancer Biology with Industry and other academic institutes like JNU, NII and others.  

Research areas pursued in the lab:

• Several reports have previously shown that NK cells in specific organs like liver, uterus and lungs show hypo-activity compared to peripheral NK. We are engaged in finding the basis for this altered NK activity and also tumour mediated alteration in NK profile in these organs.
• To study the regulation of Natural Killer cell activity and receptor expression.
• The tumour cells also employ various strategies to evade the immune system and in our laboratory we study tumour cell expressed ligand induced NK cell activity modulation.
• Evaluating the role of inflammation in cancer therapy.
• In-silico analysis of natural products for potential combinatorial cancer therapy by immunomodulation and developing drug delivery systems
• Role of HLA haplotype profile in Cancer Epidemiology.
• Role of autophagy in cancer therapeutics.

1. Assistant Professor (Biotechnology) (from July 2009-Aug 2010)

Amity University, NOIDA

 

Roles and responsibilities:

Teaching PG (MTech, MSc, MBA) and UG (B.Tech, BSc) courses:

Advanced Immunology, Introduction to Biotechnology,Cell Biology, Current topics in biotechnology

 

2. Visiting Research Fellow (From: Jan 2004-Oct 2008)

Institute: NIAID, National Institutes of Health, Maryland, USA

Advisor: Dr. Eric O. Long

 

Roles and responsibilities:

Research in Immunology and Immunogenetics

 

 

Courses taught and currently teaching to B.Tech, M.Tech & MSc Biotechnology :

• Advanced Immunology
• Immunoinformatics
• Immunotherapeutics
• Bioethics and IPR
• Microbiology and Drug Design & Discovery
• Vaccine Technology 
• Universal Human Values (AICTE) [University Co-coordinator]

• Life member of the Indian Immunology Society
• Life member of The Indian Science Congress

• Kim H. S., Das A., Gross C., Bryceson Y.T., Long E.O. (2010) Synergistic signals for natural cytotoxicity are required to overcome inhibition by c-Cbl. Immunity 32(2) 175-186.ISSN:1074-7613 Impact factor 43.4
• Madhuri Chaurasia, Asmita Das*, B.S. Dwarakanath, Anne Simonsen, Kulbhushan Sharma (Supervisor)(2019)Radiation induces EIF 2AK3/PERK and ERN1/Ire1 mediated pro-survival autophagy. Autophagy, 2019 Feb 17 (8):1391-1406. doi: 10.1080/15548627.2019.1582973 Taylor and Francis publication ISSN:1554-8627 Impact Factor 16.02
• Himanshi Singh,  Jianfeng Xiao,  Sazzad Khan,  Asmita Das,  Tayebeh Pourmotabbed,  Mohammad Moshahid Khan Persistent DNA damage response drives cGAS-STING mediated neuroinflammation in a mouse model of tauopathy, January 2025, Alzheimer's Dement., 20: e093509. DOI: https://doi.org/10.1002/alz.093509  Impact Factor 13
• Priyanka Rawat and Asmita Das* (*Corresponding author) (2022) Differential expression of disparate transcription factor regime holds the key for NK cell development and function modulation. Life Sciences 297, 120471(Elsevier). ISSN 0024-3205 Impact Factor 6.7
• Mylavarapu S, Kumar H, Kumari S, Sravanthi LS, Jain M, Basu A, Biswas M, Mylavarapu SVS, Das A*, Roy M*(*Corresponding author).Activation of Epithelial-Mesenchymal Transition and Altered β-Catenin Signaling in a Novel Indian Colorectal Carcinoma Cell Line.Front Oncol. 2019 Feb 15;9:54. ISSN 2234-943X. Impact Factor 6.2
• Simran Singh, Asmita Das, Managing cancer in autoimmune patients: Overcoming therapeutic challenges and expanding treatment options, Pathology - Research and Practice, Volume 275, September 2025, 156212, ISSN 0344-0338, https://doi.org/10.1016/j.prp.2025.156212. Impact Factor 3.2
• Ritu, Prakash Chandra and Asmita Das*, Sustained Release of Epigallocatechin Gallate from Calcium Carbonate Nanoparticles: Promising Therapy for Colorectal Cancer, April 2025, Applied Nanoscience Impact Factor 3.8
• Shweta Gulia, Prakash Chandra and Asmita Das* Combating anoikis resistance: bioactive compounds transforming prostate cancer therapy May 2024Anti-Cancer Drugs 35(Suppl 1) DOI: 10.1097/CAD.0000000000001616 Impact factor 2.1

 

• Gulia S, Chandra P, Das A. Natural Compound Dioscin Targeting Multiple Cancer Pathways through its High Affinity Binding to B Cell Lymphoma-2. Curr Comput Aided Drug Des. 2024 Feb 19. doi: 10.2174/0115734099279130231211053542. Epub ahead of print. PMID: 38375836. Impact factor 1.7

 

• Amit mathur, Ritu, Prakash Chandra and Asmita Das* (2023) Autophagy: a necessary evil in cancer and inflammation. 3 Biotech, ISSN - 2190-5738 DOI https://doi.org/10.1007/s13205-023-03864-w. Impact factor 2.8

 

• Ritu, Prakash Chandra and Asmita Das* (2023) (*Corresponding author) Cholinergic side effect-free anticancer drugs: paving the way for safer and more effective cancer treatment. Journal of Biomolecular Structure and Dynamics ISSN:0739-1102. Impact factor 4.4

 

• Ritu, Prakash Chandra and Asmita Das* (2023) (*Corresponding author) Immune checkpoint targeting antibodies hold promise for combinatorial cancer therapeutics. Clinical and experimental medicine.23(8):4297-4322. ISSN: 1591-9528. Impact factor 4.6

 

• Bhasin S, Das A. (2023) Marine alkaloid rigidin analogues as potential selective inhibitors of SHP1, a new strategy for cancer immunotherapeutics.J Biomol Structure and Dynamics. (Taylor and Francis publication) 2023 Jun 22:1-17. doi: 10.1080/07391102.2023.2227708. ISSN: 1538-0254. Impact factor 5.2

 

• Kashyap S, Das Asmita.(2023) Exploring the complex and multifaceted interplay of the gut microbiome and cancer prevention and therapy. Acta Microbiol Immunol Hung. Jun 12;70(2):85-99. doi: 10.1556/030.2023.02054. ISSN: 12178950. Impact factor 1.3

 

• Shweta Gulia, Prakash Chandra and Asmita Das* (2023) (*Corresponding author) The Prognosis of Cancer Depends on the Interplay of Autophagy, Apoptosis, and Anoikis within the Tumor Microenvironment. Cell biochemistry and biophysics.81(4) 621-658 ISSN:1085-9195.  DOI: 10.1007/s12013-023-01179-4 Impact factor: 2.6

 

• Himanshi Singh, Asmita Das, Mohammad Moshahid Khan and Tayebeh Pourmotabbed (2023) New insights into the therapeutic approaches for the treatment of taupathies. Neural Regeneration Research. ISSN: 1673-5374. Impact Factor 6.05

 

• Saksham Garg, Nikita Sharma, Bharmjeet and Asmita Das* (*Corresponding author) (2023)Unraveling the intricate relationship: Influence of microbiomeon the host immune system in carcinogenesis. Cancer Reports (Wiley Publication) pg-1-12. http://doi.org/10.1002/cnr2.1892  ISSN 2573-8348. Impact factor 1.7

 

• Ritu, Krishan Kumar Verma, Asmita Das, Prakash Chandra. (2023) Phytochemical?Based Synthesis of Silver Nanoparticle: Mechanism and Potential Applications. BioNano Science (Springer Publication) ISSN: 2191-1630 Impact Factor 3

 

• Sunil Kumar and Asmita Das* (*Corresponding author) (2023)A Cocktail of Natural Compounds Holds Promise for New Immunotherapeutic Potential in Head and Neck Cancer. Chinese Journal of Integrative Medicine (Springer Publication) ISSN:1672-0415 doi: 10.1007/s11655-023-3694-0 Impact Factor 2.6

 

• Sunil Kumar and Asmita Das* (*Corresponding author) (2023)Peripheral blood mononuclear cell derived biomarker detection using eXplainable Artificial Intelligence (XAI) provides better diagnosis of breast cancer. Computational Biology and Chemistry (Elsevier publications) ISSN: 1476-9271. Impact Factor 3.7

 

• Yuvraj Sharma and Asmita Das* (*Corresponding author) (2023) Targeting aging associated pathways: a novel therapeutic approach for cancer. Vegetos (Springer publication) ISSN:2229-4473. Impact Factor 0.2

 

• Bharmjeet and Asmita Das* (*Corresponding author) (2023)Racial disparities in cancer care, an eyeopener for developing better global cancer management strategies. Cancer Reports (Wiley Publication) ISSN: 2573-8348. Impact Factor 1.9

 

• Preksha Jain and Asmita Das* (*Corresponding author) (2023) Identifying tinospora cordifolia bioactivecompounds with the greatest inflammatory therapeutic potential. International Journal of Advances in Science Engineering and Technology. Vol 11, Issue 2, Pg 2321-8991. ISSN 2321-8991. Impact Factor 3.15

 

• Namit Dey, Deenan Santhiya and Asmita Das (2023) One-Pot synthesis of Doxorubicin-bioactive glass ceramic hybrid nanoparticles through a bio-inspired route for anti cancer therapy. Chemistry Select (Wiley publication) ISSN: 2365-6549 Impact factor 2.3

 

• Muskaan Dhingra, Shayon Mahalanobis and Asmita Das* (*Corresponding author) (2022) Thyroid receptor B might be responsible for breast cancer associated with Hashimoto’s thyroiditis: a new insight into pathogenesis. (2022) Immunologic Research, Springer, Vol 70, 441-448. ISSN: 0257-277X Impact Factor 4.5

 

• Gunjan Sachdeva and Asmita Das* (*Corresponding author) (2022) Communication between immune system and mycobiota impacts health and disease. Proc. Indian Natl. Sci. Acad.(Springer) 88; 250-262doi: 10.1007/s43538-022-00082-5 ISSN: 0370-0046 Impact Factor 0.3
• Namit Dey, Deenan Santhiya and Asmita Das (2022) Bio-Inspired Synthesis of Hollow Mesoporous Bioactive Glass Nanoparticles Using Calcium Carbonate as Solid Template. Chemistry Select. 7,12, 1-7. ISSN 2365-6549. Impact factor 2.3
• Sunil Kumar and Asmita Das* (*Corresponding author) (2022) Elucidation of natural compounds Gallic acid and Shikonin for the treatment of HNSC cancer by targeting immune suppressor and tumour progression genes. Vegetos, Springer publications 35; 880-894. ISSN: 2229-4473https://doi.org/10.1007/s42535-022-00363-w Impact Factor 0.2

 

• Saksham Garg, Sunil Kumar, Ashutosh Anand, Tarunya Menon, Nikita Sharma, Japneet Singh, Siddharth Chawla and Asmita Das* (*Corresponding author) (2022)Plant derived natural compounds aiding SOCS1 mediated JAK1 inhibition, a novel mechanism of combinatorial cancer chemotherapy. Vegetos, Springer publications 35; 707-722 ISSN: 2229-4473 Impact Factor 0.2

 

• Ritika Luthra, Shreeja Datta and Asmita Das* (*Corresponding author) (2022) Mathematical Models are Crucial in Development of Novel Strategies for Cancer Treatment. Research Journal of Biotechnology. Vol 17 (6) 204-219. ISSN: 09736263 Impact Factor 0.4

 

• Amit Mathur, Vikas Dhikav, Bhargavi Jadeja, and Asmita Das (2021) Digital device usage and subjective memory complaints during COVID-19 pandemic among young adults. J Neurol Sci.Oct; 429: 119062 doi: 10.1016/j.jns.2021.119062 Impact Factor 4.53

 

• Niharika Gupta, Shine Augustine, Tarun Narayan, Alan O’Riordan, Asmita Das, D. Kumar, John H. T. Luong, Bansi D. Malhotra (2021) Point-of-Care PCR Assays for COVID-19 Detection. Biosensors (Basel) 2021 May; 11(5): 141 ISSN 2079-6374 Impact Factor 5.7

 

• Reetika Singh and Asmita Das* (*Corresponding author) (2021) The Role of TLRs in the Immunomodulation of Tumor Microenvironment. Research Journal of Biotechnology. Vol 17(2)173-180. ISSN: 09736263 Impact Factor 0.4

 

• Sneha Iyer and Asmita Das* (*Corresponding author) (2021) Stem Cell Therapy for infectious diseases like COVID 19 - A Review. Journal of Stem Cells. Vol 16, No.2-3. 73-90. ISSN 1556-8539 Impact Factor 2.4

 

• Reeya Tanwar and Asmita Das (2021) Identification of Drug targets for AKT-1 in Proteus syndrome in silico docking studies. IJASET 9; 3; 34-38 ISSN:2321 –8991 Impact Factor 3.15

 

• Sneha Iyer and Asmita Das (2020) Targeting Wnt Pathway in Cancer Stem Cells for anti cancer therapy. International Journal of Advances in Science, Engineering and Technology. Vol 8; 4; pg 4-7 ISSN 2321-8991 Impact Factor 3.15

 

• Bhatia K, Bhumika and Das Asmita* (*Corresponding author) In silico analysis of drug molecules to perform drug repurposing against variety of cancer targets. IJASEAT (2020) Vol 8, Issue 3; pg 35-41.ISSN 2321-8991. Impact Factor 3.15

 

• Shaleen Jain and AsmitaDas* (*Corresponding author) Virtual screening of natural compounds as combinatorial agents from Indian medicinal plants against estrogen positive breast cancer. International Journal of Integrated Education(2020)Vol 3, No.10; 266-275 ISSN 2620-3502 Impact Factor 3.2

 

• Sachin Singh and Asmita Das (2020) Study of Brain Region Segmentation using Convolutional Neural Network. International Journal on Orange Technologies. Vol 2; Issue 10; Pg 66-75. ISSN 2615-7071Impact Factor 1.0
• Bhatia K, Bhumika, Das Asmita* (*Corresponding author) Combinatorial drug therapy in cancer-New insights. Life Sciences (Elsevier) ISSN 0024-3205 (2020) Vol 258, 118134 Impact Factor 6.7

 

• Kumari N, Das A, Bhatt A (2020) Interleukin-6 confers radio-resistance by inducing Akt mediated glycolysis and reducing mitochondrial damage in cells. Journal of Biochemistry (Oxford Univ Press) 167; 3. Pg 303-314 ISSN 1756-2651, doi: 10.1093/jb/mvz091. [Epub ahead of print] Impact Factor 3.4
• ·Vani Venugopal and Asmita Das* (*corresponding author) (2019)Elucidating the mechanism of action of Crocin, a therapeutic agent for cancer and inflammation. International Journal of biotechnology and Biomedical Sciences. Vol 5; 1; 48-52. ISSN: 2454-4592. Impact Factor 0.68

 

• ·Sunil Kumar and Asmita Das* (*corresponding author) (2019) Therapeutic target prediction of tumor specific antigen for vaccine design International Journal of biotechnology and Biomedical Sciences. Vol 5; 1; 57-60. ISSN: 2454-4592. Impact Factor 0.68

 

• ·Sharma R, Das A*.(*corresponding author)(2018) In silico approach to study affinity of NK cell inhibitory receptor interaction with classical and non classical ligands Archives of Immunology and Allergy 1, (2) 40-53 ISSN: 2639-1848 Impact Factor 0.92

 

• ·Mylavarapu S, Das A*, Roy M.(2018)(*Supervisor) Role of BRCA Mutations in the Modulation of Response to Platinum Therapy.Frontiers in Oncology 8(16). Doi:0.3389/fonc.2018.00016. Ecollection 2018.ISSN: 2234-943X Impact factor 6.2

 

• Sharma R, Das A*. (*corresponding author)(2018) IL-2 mediates NK cell proliferation but not hyperactivity.Immunol Res. 66(1):151-157. doi: 10.1007/s12026-017-8982-3.Springer Publication ISSN: 0257-277X Impact Factor 4.5

 

• Augustine S, Singh J, Srivastava M, Sharma M, Das A, Malhotra BD.(2017) Recent advances in carbon based nanosystems for cancer theranostics. Biomaterial Sci. 5(5):901-952.ISSN 2047-4849Impact Factor 7.5

 

• Dholakia D, Goyal S, Jamal S, Singh A, Das A, Grover A(*Supervisor) Molecular modeling and lead design of substituted zanamivir derivatives as potent anti-influenza drugs BMC Bioinformatics. 2016 Dec 22;17(Suppl 19):512. doi: 10.1186/s12859-016-1374-1.B (Online)ISSN 1471-2105. Impact Factor 3.3

 

• Richa Mishra, Ruchi Verma, Sakshi Shreni, Jaspreet Kaur, Divya Joshi, Asmita Das*(*corresponding author) (2016) Evaluating the basis for NK sensitivity and NK resistance in prototypic NK sensitive and resistant cell line. JSM Chemistry 4(4) 1035 ISSN: 2334-1831

 

• Kumari N, Dwarakanath B S, Das A*., Bhatt. A.N. (2016) (*Supervisor) Role of IL-6 in cancer progression and therapeutic-resistance. Tumor Biology Sep;37(9):11553-11572. ISSN: 1010-4283 (printversion)1423-0380 (electronic version) Impact factor: 3.6

 

• Chaurasia M., Bhatt A., Das A*., Dwarakanath B., Sharma K (2016)(*Supervisor)Radiation induced autophagy: Mechanisms and consequences. Free Radical Research ;50(3):273-90 ISSN: 1071-5762 (Print) 1029-2470 (Online) Impact Factor 4.2

 

• Chaurasia M, Misra S., Bhatt A. N., Das A., Dwarakanath B., Sharma K. (2015) (*Supervisor)Metabolic imbalance associated mitophagy in tumor cells: Genesis and implications Journal of Cancer Research Updates, 4, 95-107 ISSN: 1929-2279 Impact Factor 0.2

 

• Das A (corresponding author) and Dhanjal J K. (2015) Medicinal plants, a gold mine of anticancer compounds American International Journal of Research in Formal, Applied & Natural Sciences ISSN (Print): 2328-3777, ISSN (Online): 2328-3785, ISSN (CD-ROM): 2328-3793 9(1), December-2014 to February- 2015,14-23.

 

• Dhanjal J K, Sharma S., Grover A., Das A* (*corresponding author)(2015)Use of ligand-based pharmacophore modeling and docking approach to find novel acetylcholinesterase inhibitors for treating Alzheimer’s. Biomedicine & Pharmacotherapy 71 (2015) 146–152 Elsevier Publication ISSN: 0753-3322. Impact factor 6.5

 

• Sharma R and Das A* (*corresponding author) (2014) Organ specific phenotypic and functional features of NK cells in humans. Immunologic Research,58, no. 1, 125-131,Springer Publication ISSN: 0257-277X (DOI 10.1007/s12026-013-8477-9) Impact factor: 4.5

 

• Kaur H, Sharma R and Das A* (*corresponding author) (2013) “Mir”acles in Neuro Molecular Medicine. International Journal of Biotechnology and BioinformaticsVol.2, Issue.1, 19-26. ISSN: 2319-9334 Impact Factor 0.98
• Das, A. and Long E.O. Granule polarization in NK cells is a better target for inhibition than degranulation.(2010) Journal of Immunology 185, 4698-4704. ISSN:0022-1767(Selected among the top 10% articles published in the journal in 2010). Impact Factor 5.7

 

• Das, A. and Saxena, R.K. (2004) Role of interaction between Ly49 receptors and cognate MHC I molecules in IL2 induced development of NK cells in murine bone marrow cell cultures. Immunology Letters 94 (3), 209-214 Elsevier Publication ISSN:0165-2478 Impact Factor 2.8.

 

• Das, A., Gupta M. and Saxena, R.K. (2004) Enhanced activation of murine NK cells by IL2 in presence of circulating immune complexes. Current Science 87 (6) 780-783(ISSN:0011-3891). Impact Factor 1.1

 

• Das A., Dhillon S., and Saxena R.K. (2003) A chapter, “Modulation of NK cell activation by tumor cells: Role of MHC I molecules and their receptors” in book titled “Progress in Haematologic Oncology” published by The Advanced Research Foundation, New York.

 

• Das A., Sarin A. and Saxena R.K. (2002) Modulation of NK cell activation and interaction with target cells. Proc. Nat. Acad. Sci. (India) B69, No.1, 47-60 (ISSN:0370-0046). Impact Factor 0.96

 

• Das, A. and Saxena, R.K. (2001) Abrogation of tumor induced KIR expression on mouse spleen cells by Mitomycin C. Immunology Letters 77 (2), 73-77 Elsevier Publication ISSN:0165-2478). Impact Factor 2.8

 

• Dhillon, S., Das, A and Saxena, R.K. (1999) Activating and Inhibitory receptors on Natural Killer cells. Proc. Nat. Acad. Sci. (India) 69 (B), 229-243(ISSN:0370-0046). Impact Factor 0.2

 

Book(s):

• Dr. Asmita Das Editor of Book, “Microbial Crosstalk with Immune System” published by Elsevier Publication ISBN: 9780323961288 (2022)

Book Chapters:

• Shweta Gulia, Simran Singh, Nida E Falak1, Bhupendra Pratap Singh, Ravi Butola, Asmita Das and Prakash Chandra, Sensors for monitoring global deposition of pollutants in aquatic ecosystems, Sensors for Marine Biosciences, Next-generation sensing approaches, IOP Publishing Ltd 2025
• Ritu, Bharmjeet, Nida-e-Falak, Rahul gupta, Asmita Das and Prakash Chandra Nanoscience in controlled drug release in the gastrointestinal tract, June 2024, book: Nanobiotechnology and Artificial Intelligence in Gastrointestinal diseasesPublisher: IOP, DOI: 10.1088/978-0-7503-6134-7ch3
• Ritu, Apoorva, Simran Singh, Prakash Chandra, and Asmita Das, "Nanotechnological aspects and future perspective of nanocoatings for medical devices and implants," Next-Generation Antimicrobial Nanocoatings for Medical Devices and Implants, Woodhead Publishing, 2024. DOI: 10.1016/B978-0-323-95756-4.00005-1
• Shweta Gulia, Vanshika Kothari,  Ritu, Smita Rastogi Verma, Asmita Das, Bhupendra Pratap Singh, Prakash Chandra,11 - Bioremediation of PAHs using nanotechnology, Editor(s): Charles Oluwaseun Adetunji, Ravindra Pratap Singh, Jay Singh, Kshitij RB Singh, In Micro and Nano Technologies, Nanobiotechnology for Bioremediation, Elsevier, 2023, Pages 249-271, ISBN 9780323917674.
• Ritu, Shruti Sounkaria, Gunjan Sachdeva, Asmita Das, Smita Rastogi Verma, Saurabh Chandra Saxena, Bhupendra Pratap Singh, Shakilur Rahman and Prakash Chandra. (2023) Book Chapter “Potentialities of nanotechnology in nutrient management in the livestock products”Elsevier, 2023, Pages 111-137, ISBN 9780323983877
• Das Asmita (2020) (Book Chapter) Isolation of Natural Killer Cells from Mouse Bone Marrow and Spleen. (Chapter 11) Experimental Protocols in Biotechnology (Springer) ISBN 978-1-0716-0607-0 pg 183-192
• Dr. Asmita Das Editor of Book, “Proceedings of International Conference on Innovations in Biotechnology and Life Sciences” published by INSHA Publication ISBN: 978-93-88647-32-8 (2020)
• Divya Joshi, NausheenTickoo, Chatanya Jain, Asmita Das* (*corresponding author) Advances in Cancer Immunity, A Formidable Army (Book Chapter) in Advances in biotechnology ISBN: 978-81-935757-0-3. Chapter1 (pp1-13) (2018)
• Awasthi K., Prasad T and Das A*. (*Corresponding Author)(2016) Detection of multidrug resistant fungal infections in cancer patients (Book Chapter) Molecular Markers in Mycology (Springer)ISBN 978-3-319-34106-4
• Parnika, Harshal and Asmita Das* (*corresponding author) (2013) Bioremediation of Concrete,IIE INT’L Conference Proceedings of International Conference on Emerging Trends in Engineering and Technology, 123-127. (ISBN: 978-93-82242-52-9)
• Das A., Dhillon S., and Saxena R.K. (2003) A chapter, “Modulation of NK cell activation by tumor cells: Role of MHC I molecules and their receptors” in book titled “Progress in Haematologic Oncology” published by The Advanced Research Foundation, New York.

 

• DTU Research Excellence Award Recipient
• NET & Junior Research Fellowship (JRF) qualified in 21 DEC.1997 (in top category) Council of Scientific & Industrial Research (CSIR) (Govt. of India)
• Council of Scientific & Industrial Research (CSIR) (Govt. of India)-
• Senior Research Fellowship qualified in Nov 2001
• Department of Bio-Technology (DBT) scholarship from Govt. of India - MSc. in Biotechnology (1995-97)
• Central Board of Secondary Education (CBSE) National Scholarship in1992
• AISSE (CBSE) Board topper in Biology and Physics

• Principal Investigator in Completed Research Project funded by DST (under Fast Track Scheme for Young Scientist) for Rs 20.2L: Tumor cell induced NK cell receptor modulation
• Principal Investigator of DTU Research Project Grant: Preparation of tumor targeting monoclonal Antibody and Crocin nanoparticle conjugate for drug delivery system
• Co investigator in UPE JNU: Studies on elucidating Silver Nanoparticle as potent inhibitor of hyphal morphogenesis and drug resistance in opportunistic fungal pathogen, Candida and potential host cell toxicity
• Principal Investigator of DTU Interdisciplinary Research Grant: Paint mediated Self-healing of cracks by incorporation of bacteria: A New Paradigm in Sustainability

 

• Two Week Faculty Development Programme on ADVANCES IN TEACHING PEDAGOGY & RESEARCH METHODOLOGY organized by Delhi School of Management, Delhi Technological University, from 14th  July to 25th  July, 2025.
• ATAL Faculty Development Program 2^nd to 7^th December, 2024 on Waste To Wealth Innovation organized by National Institute of Technical Teachers Training & Research, Kolkata, sponsored by AICTE ATAL
• One week Faculty Development Program on Disaster Preparedness And Risk Reduction by Department of Civil Engineering, DTU held from 11^th to 15^th December, 2023
• Two-Week Capacity Building Program for University Technology Business Incubator by PUM Netherlands Senior Experts organized by DTU-IIF20^th to 30^th November, 2023 
• Faculty Development Program 17^th to 22^nd Jan 2022 on Research Methodology and Online Teaching, organized by IIT Guwahati
• Faculty Development Program 19^th July- 23^rd July 2021 “Leadership mastery through self- management” organized by DTU and Heartfulness Education Trust
• Faculty Development Program 15^th Apr-19^th Apr 2021 “Ethics and Values in Technical Education in the context of NEP 2020” organized by DTU
• Short term training program on Information Security in the Era of Deep Learning: Challenges &Opportunities organized by DTU from 8^thFeb to 12^th Feb 2021.
• One Day Workshop on 22^nd May 21 “Research Methodology” organized by SreeVidyanikethan Engineering College
• Faculty Development Program 28^th June- 4^th July 2020 “Waste to Bioenergy” organized by Dept Of Life Sciences, Sharda University, UP and Dept. of Agricultural Engineering, Maharashtra Institute of Technology,Aurangabad
• 1 week Faculty Development Program 10^th-14^th July 2020 Trends and prospects in Biorefinery organized by NIT, Jalandhar
• Organizing Committee member: “Advanced Pedagogy, IPR, Sponsored Research and Entrepreneurship” organized by Engineering Staff College of India and DTU from 16^th to 20^th July 2019
• TEQIP III sponsored one week short term training programme on “Recent Trends in AI and Machine Learning in DTU” from 29^th July- 2^nd Aug 2019
• TEQIPIII sponsored One Week Short Term Training Programme on “Health, Human Values, Ethics and Empowerment” organized by Dept. of IT, DTU from 13^th -18^th Apr 2018
• TEQIPIII sponsored One Week Faculty Development Programme on “Recent Developments in Translational Medicine” organized by Dept. of Biotechnology, DTU from 12^th -16^th Mar 2018
• TEQIPIII sponsored One Week Faculty Development Programme on Advances in Surface Engineering organized by Dept. of Mechanical Engineering, DTU from 1^st-5^th May 2018
• Mendeley Presentation on Improvement of Research Workflow on 12^th Oct 2018
• Two weeks Faculty Development Programme on “Advanced Manufacturing and Operations Management (AMOM-2017) organized by Centre for Advanced Production and Industrial Engineering Research, Dept. of Mechanical Engineering, DTU from 3^rd- 14^th July 2017
• Short Term Training Programme on Research Methodology from 14^th Dec to 18^th Dec 2016 at DSM, Delhi Technological University
• 90^th Orientation Programme at Jawaharlal Nehru University from 7^th Apr to 2^nd May 2014 securing Grade A (above 75%)
• 1^st Refresher Course in Life Sciences and Biotechnology at Jawaharlal Nehru University from 20^th July 2015-14^th Aug 2015 securing Grade A (above 75%)
• 2^nd Refresher Course in Life Sciences and Biotechnology at Jawaharlal Nehru University from 3^rd Oct 2016-28^th Oct 2016 securing Grade A (above 75%)
• 2 week refresher course at Delhi Technological University (TEQIP)“Advanced Web Designing Techniques” 14-25 July 2014
• Refresher course at IIT, Delhi (TEQIP) “Modelling and Decision Making Techniques in Engineering and Management” 19^th-21^stMarch 2015
• Faculty Development Programme (TEQIP) 2 week refresher course at Delhi Technological University on “Automation in Manufacturing” from 4^th-15^thMay 2015
• 1week Faculty Development Programme (TEQIP) on Advances in Information Security 18-22 Jan 2016 at Delhi Technological University
• 1week Faculty Development Programme (TEQIP) on Recent Trends in Geoenvironmental Engineering from 18^th-22^ndApr 2016 at Delhi Technological University 
• Faculty Development Programme (TEQIP) 1 week FDP course at Delhi Technological University on “Geotechnical Engineering for Urban Infrastructure” from 11^th-15^thJuly 2016
• 1 week Faculty Development Programme (TEQIP) on “Research and Publications” at Delhi Technological University from 25^th -29^th July 2016.

 

• Invited lecture in IIT Guwahati “NK CELLS, A KEY RUNG IN development of  IMMUNOTHERAPEUTICS AS COMBINATORIAL CANCER THERAPY” in online mode 11th Apr 2022
• Invited lecture in 2^nd International Conference on Environment, Agricultural, Chemical and Biological Sciences from Jan 24-26, 2021 organized by Voice of Indian Concern for the Environment (VOICE) in association with CAFRE, University of Pisa, Italy; Murray State University, Murray, Kentucky, USA; GLA University, Uttar Pradesh; Mercy College, Kerala; DM College of Science, Manipur; Vels University, Chennai, India “Natural killer cells: a formidable force against tumors and viruses”
• Invited lecture in Symposium: Emerging Trends in Translational Oncology, AIIMS on 14^th -15^th Feb 2020. “NK cell and tumor cell interaction, understanding new paradigms”
• Invited lecture as part of Popular Lecture series sponsored by DBT at Dept. of Biotechnology, CSJM University, Kanpur from 20^th July to 21^st July 2018
  • Topic: “Innate System: A Formidable army to reckon with”
• Invited lecture at Department of Medical Oncology, AIIMS New Delhi on 6th September 2016
  • Topic: NK cells: Old Dog with New Tricks
• Invited lecture at the Industry-Academia Meet in NPL, New Delhi. 13 Dec 2012
  • Topic Frontiers of Biotechnology
• Chairperson: Biotechnology Session in National Conference on Innovation in Engineering
• Organizing Committee member in
• Convenor: Student Career Guidance outreach activity- “ Converting Innovation into a startup” organised in DTU on 29^th July 2022
• Convenor: International Conference on Innovations in Biotechnology and Life Sciences 18^th -20^th Dec 2020
  • Participants:1200 approx. from more than 20 countries, 500 abstracts approx.
• Organizing Committee member: DTU sponsored International E-workshop on Bioinformatics 14^th-18^th Dec 2020
• Organizing Committee member: One day International E-Symposium on Women in Science held on 11^th Feb 2021
• Organizing Committee member: “Advanced Pedagogy, IPR, Sponsored Research and Entrepreneurship” organized by Engineering Staff College of India and DTU from 16^th to 20^th July 2019
• National Conference in Biotechnology and Bioinformatics in DTU (2010)
• India-Japan workshop on “Biomolecular Electronics and Organic Nanotechnology for Environment Preservation” (2013)
• Invited expert on Selection Committee Indian Patent Office
  • Invited expert as Selection Committee Member: DRDO Cash Awards, 2014
  • Invited expert as Expert Committee Member: DRDO Fellowship Review Board, 2014
• Paper Setter for JNU Entrance Examination, IGNOU PhD Entrance Test in Engineering and Technology
• Paper setter for end sem examinations in UG and PG courses in IP University; School of Engineering and Technology, IGNOU, Kashi Vidyapeeth.
• Question paper moderator for Annual Examinations in School of Engineering and Technology, IGNOU
• External Examiner in Shaheed Rajguru College of Applied Sciences, Delhi University; Kanpur University
• External Expert in Institutional Biosafety Committee in India Innovation Research Centre (Academia-Industry partnership)

RESPONSIBILITY OF NATIONAL SIGNIFICANCE: Sector Officer and Presiding Officer in Lok Sabha Elections 2014 and MCD Elections 2017

ADMINISTRATIVE RESPONSIBILITIES: 

At University Level:

Associate Dean, Corporate Relations

Member of University Purchase Committee

Integrated MSc Admission Co-coordinator since inception of course in 2024

Member Doctoral Research Committee (Civil Engineering Dept)

Member Selection Committees (Confidential)

Member Secretary NAAC Criteria 6 preparation

In Department of Biotechnology:

Practical Superintendent

Ph D Coordinator

Coordinator Integrated BSc-MSc ; MSc ; MTech Bioinformatics; BTech Data Science (upcoming)

Time Table Coordinator

Doctoral Research Committee member

Member of Departmental Board of Studies

Coordinator Curriculum Revision committee

INDUSTRIAL TRAINING:

2 weeks Industrial Training in AVAADA ENERGY PVT LTD from 12 June 2023 to 24th June 2023